White Matter Lesion Volumes on 3-T MRI in People With MS Who Had Followed a Diet and Lifestyle Program for More Than
Mariaan Jaftha1,2, Frances Robertson2,3, Susan J van Rensburg4
1Department of Medical Imaging and Therapeutic Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Bellville, Cape Town, South Africa.
Abstract:
Background: Cerebral white matter lesion (WML) formation in people with multiple sclerosis (pwMS) is linked to the death of myelin-producing oligodendrocytes. Current MS treatment strategies focus on limiting WML accumulation and disability. Using a pathology-supported genetic testing (PSGT) program, we identified specific risk factors for MS, categorized as deficiencies and aggravators. We developed a novel clinical methodology to mitigate these risk factors, including personalized lifestyle interventions and optimization of cerebral nutrients to prevent oligodendrocyte demise and promote remyelination. Objective: To conduct a pilot case-control study over a 10-year period to ascertain whether the PSGT Program can reduce or prevent WML formation in pwMS. Methods: MRI was performed at baseline as well as after an interval period of at least 10 years or longer in 22 pwMS. WML volumes were determined using Sequence Adaptive Multimodal SEGmentation (SAMSEG) software, part of FreeSurfer 7.2. Other variables included age at MRI, disease duration, disability status, and medication. Results: PwMS (n = 13) who had followed the PSGT program for more than 10 years, had significantly smaller lesion volumes (mm3) compared to pwMS who did not adhere to the program (n = 9) (4950 ± 5303 vs. 17934 ± 11139; p = 0.002). WML volumes were significantly associated (p = 0.02) with disability (EDSS) but not with age (p = 0.350), disease duration (p = 0.709), or Interferon-β treatment (p = 0.70). Conclusion: Dietary and lifestyle changes may lower the risk of developing cerebral WMLs in pwMS and potentially slow disease progression. Larger studies are required to confirm the effectiveness of such interventions in pwMS.
Insights
A pathology-supported genetic testing (PSGT) program, including lifestyle changes, significantly reduced white matter lesion (WML) volumes in people with multiple sclerosis (pwMS). This suggests interventions may slow disease progression in MS patients.
Area of Science:
- Neuroscience
- Genetics
- Immunology
Background:
- Cerebral white matter lesion (WML) formation in multiple sclerosis (MS) is linked to oligodendrocyte death.
- Current MS treatments aim to limit WML accumulation and disability.
- A novel pathology-supported genetic testing (PSGT) program identified MS risk factors (deficiencies, aggravators) and developed mitigation strategies.
Purpose of the Study:
- To assess if the PSGT Program can reduce or prevent WML formation in people with MS (pwMS).
- A pilot case-control study was conducted over a 10-year period.
Main Methods:
- 22 pwMS underwent baseline and 10-year follow-up MRI scans.
- White matter lesion (WML) volumes were quantified using Sequence Adaptive Multimodal SEGmentation (SAMSEG) software.
- Data included age, disease duration, disability status (EDSS), and medication.
Main Results:
- PwMS adhering to the PSGT program (n=13) showed significantly smaller WML volumes (4950 ± 5303 mm³) compared to non-adherent pwMS (n=9) (17934 ± 11139 mm³; p=0.002).
- WML volumes correlated significantly with disability (EDSS, p=0.02).
- No significant association was found with age (p=0.350), disease duration (p=0.709), or Interferon-β treatment (p=0.70).
Conclusions:
- Dietary and lifestyle modifications, guided by PSGT, may reduce cerebral WMLs in pwMS.
- These interventions show potential for slowing MS disease progression.
- Larger studies are needed to confirm the efficacy of these interventions in pwMS.
Related Concept Videos
Magnetic Resonance Imaging
Multiple Sclerosis l: Introduction


